Showing results (1331-1340 of 1,485) with videos related to
Sort By:
Pageof 149
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.Genetics|October 30, 2015
Genome-Wide Structural Variation Detection by Genome Mapping on Nanochannel ArraysAngel C Y Mak, Yvonne Y Y Lai, Ernest T Lam, et al.Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021Robert J Motzer, Eric Jonasch, Shawna Boyle, et al.Nature|January 24, 2020
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancerEmily J Faivre, Keith F McDaniel, Daniel H Albert, et al.Nature Genetics|March 7, 2017
Single-molecule sequencing and chromatin conformation capture enable de novo reference assembly of the domestic goat genomeDerek M Bickhart, Benjamin D Rosen, Sergey Koren, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.Nature|June 6, 2020
A calcineurin-Hoxb13 axis regulates growth mode of mammalian cardiomyocytesNgoc Uyen Nhi Nguyen, Diana C Canseco, Feng Xiao, et al.Cancer Immunology, Immunotherapy : CII|May 29, 2023
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 studyMatteo Santoni, Zin W Myint, Thomas Büttner, et al.Pageof 149